ARMI's mission is to make practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones.
ARMI's BioFabUSA program is designed to attract and develop an ecosystem of both large and small industrial/commercial institutions. Given the nascent stage of the regenerative manufacturing industry, this includes Tissue-Engineering and Regenerative Medicine (TERM) startup companies as well as larger firms that see this as an attractive adjacent market opportunity. Also included in this ecosystem are educational, medical and mission driven non-profit institutions whose areas of research, areas of practice or philanthropic mission include, or could benefit from, TERM or TERM related therapies or technologies. This includes organizations whose mission align with the prospect of developing TERM therapies to help cure certain diseases (e.g., diabetes, renal failure and limb loss) or advancing the tissue manufacturing industry (e.g., engineering/scientific societies and standards development organizations).
Over the last 10 years, Cal Poly has provided well-trained graduates for the Regenerative Medicine Industry through a Regenerative Medicine Interdisciplinary Program that integrates students and faculty from Biomedical Engineering, Biological Sciences, and Animal Science.
Scientists have taken a major step closer to being able to 3D bioprint functional organs by devising a method of rebuilding components of the human heart. FluidForm, a new ARMI member, is making this technology available for research and commercial applications, with the ultimate goal to revolutionize regenerative medicine and impact millions of Americans every year.
Progenesis Technologies LLC, a Huntington, WV bio-engineering company, says producing customized molecular scaffolds from alginate products has a “fundamental advantage over seaweed derived alginates in cost efficiencies and customization for various applications,” according to Gardiner F.H. Smith, Executive Chairman.
CAST, a nonprofit organization headquartered in Wakefield, MA, believes learning should have no limits. Founded in 1984, by education researchers, CAST created the Universal Design for Learning (UDL) framework, a set of principles based on learning sciences including neuropsychology, human development, and education research.
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions in sport medicine and severe burn cases and is a leader in the development of autologous cell therapies to repair or restore damaged tissues or organs.
Pluristyx was established in 2018 with the goal of solving challenges associated with cell manufacturing by manufacturing GMP grade pluripotent stem cells at large scale for use as a universal starting material for the further manufacturing of therapeutic regenerative medicine products.
RoosterBio was founded in 2013 to specifically address the industry-wide bottleneck that is the scarcity of high quality and scalable cellular starting materials for product development and clinical manufacturing, is a pioneer in Regenerative Medicine (RM) manufacturing, with a focus on human mesenchymal stem/stromal cells (hMSC) raw materials, bioprocess design, and production technologies.
Sudhin Biopharma is an early-stage Biopharma technology development company located in Superior, CO, founded in 2014 by Prof. Dhinakar Kompala, after taking early retirement from his faculty position in the department of Chemical and Biological Engineering at the University of Colorado, Boulder.
Trailhead Biosystems, headquartered in Cleveland, Ohio, merges developmental biology and cell therapeutics with cutting edge hardware, computerized experimental design, and analysis to perform process-specific parameter optimization in the development of cell therapies.
AlloSource is a 501(c)3, not-for-profit organization, headquartered in Centennial, Colorado with approximately 500 employees dedicated to advancing the science and use of transplantable allogeneic cells and tissue through pioneering research in regenerative therapies.
ArunA Bio, located in Athens, Georgia, with nearly 20 employees, was founded in 2005 as a developer and manufacturer of human neural-specific cell lines. The company has since transformed into a drug development company with a duel focus platform technology.
BCS was founded in 2011 and is headquartered in Rockland, Massachusetts. The company designs and implements custom technology roadmaps for Life Science & Manufacturing companies delivering end-to-end IT and communications solutions that are cost-effective and match specific operational needs.
For over 40 years in the US and 80 years globally, Festo has been a positive force for manufacturers with a passion for automation productivity — intelligent automation solutions that transform the way people work — and the way companies compete.
GSGWM offers a wide variety of outcomes-based STEM programs to over 10,000 girls across Vermont and New Hampshire every year and it is one of just a few of Girl Scout councils in the US to see membership growth for three consecutive years.
Robert J. Tomasetta founded Automated Control Concepts Inc. (ACC) in 1983, leaving the confines of the General Electric Programmable Logic Controller (PLC) business to open ACC’s first office in Union, New Jersey. He focused on programming those, at the time, very “mysterious” programmable controller devices.
Nearly twenty years ago, Dr. Marc Hedrick at Cytori Therapeutics predicted that in years to come humans would someday donate their adult stem cells from fat tissue the way blood was, and is, donated today in order to cure diseases.Fast forward to 2019 and Dr. Jeffrey Gimble, CEO of LaCell is doing just that and more.
Founded in 2016, Modal Technology Corporation is a privately-owned Minnesota corporation that offers new innovative solutions for machine learning. Headquartered in Minneapolis, with a team of four, the company is involved in the development of industry standards in machine learning and has a vision of introducing the benefits of its patented technology to many vertical markets including finance, aerospace, defense and Regenerative Medicine in the healthcare sector.
Northwestern University Research Institutes and Centers sit at the intersections of traditional disciplines to increase the innovation, productivity, and cross-fertilization needed to solve great societal challenges.
BCSI, now known also known as SAFE Sens, is an international laboratory instrument as well as a medical device company. It offers sterile automated fluoroscopic evaluation (SAFE Sens) for media; pH SAFE systems for blood; and simple nucleic acid processing systems for genomic research serving patients, clinicians, researchers, pathologists, and doctors worldwide.
Skeletal Tissue Engineering Laboratory (STEL) Technologies LLC, is an Ann Arbor based Regenerative Medicine company that engineers biological tissue implants for tissue replacement and repairs to musculoskeletal injuries.
“What if we could glue broken bones instead of using casts, rods, pins, and screws? What if we could glue soft-tissues, muscles, tendons, or cartilage instead of using sutures? What if we could reinforce weakened osteoporotic bones before they failed? If we had the right materials, we could,” said Darren Nolen, Founder & CEO of Nolen Ortho located in Middleton, NH.
Nanofiber Solutions, Inc. is a Regenerative Medicine company developing a new class of implants for the $20B soft tissue, organ repair, and regeneration market. The technology is used to build off-the-shelf scaffolds that are critical in the development of life-saving and life-changing, tissue engineered implants for humans and animals.